IL217298A0 - 3-cyanoquinoline tablet formulations and uses thereof - Google Patents
3-cyanoquinoline tablet formulations and uses thereofInfo
- Publication number
- IL217298A0 IL217298A0 IL217298A IL21729811A IL217298A0 IL 217298 A0 IL217298 A0 IL 217298A0 IL 217298 A IL217298 A IL 217298A IL 21729811 A IL21729811 A IL 21729811A IL 217298 A0 IL217298 A0 IL 217298A0
- Authority
- IL
- Israel
- Prior art keywords
- cyanoquinoline
- tablet formulations
- formulations
- tablet
- cyanoquinoline tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22253709P | 2009-07-02 | 2009-07-02 | |
PCT/US2010/040555 WO2011002857A2 (en) | 2009-07-02 | 2010-06-30 | 3-cyanoquinoline tablet formulations and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL217298A0 true IL217298A0 (en) | 2012-02-29 |
Family
ID=42732381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL217298A IL217298A0 (en) | 2009-07-02 | 2011-12-29 | 3-cyanoquinoline tablet formulations and uses thereof |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP2448563A2 (en) |
JP (1) | JP2011012063A (en) |
KR (1) | KR20120046216A (en) |
CN (1) | CN102470109A (en) |
AR (1) | AR077546A1 (en) |
AU (1) | AU2010266342A1 (en) |
BR (1) | BRPI1015941A2 (en) |
CA (1) | CA2766067A1 (en) |
IL (1) | IL217298A0 (en) |
MX (1) | MX2012000048A (en) |
RU (1) | RU2011152105A (en) |
SG (1) | SG177309A1 (en) |
TW (1) | TW201113050A (en) |
WO (1) | WO2011002857A2 (en) |
ZA (1) | ZA201200366B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006210572B2 (en) | 2005-02-03 | 2011-08-04 | The General Hospital Corporation | Method for treating gefitinib resistant cancer |
CN103110948A (en) | 2005-11-04 | 2013-05-22 | 惠氏公司 | Antineoplastic combinations with mTOR inhibitor,herceptin, and/or HKI-272 |
US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
CA2725598C (en) | 2008-06-17 | 2013-10-08 | Wyeth Llc | Antineoplastic combinations containing hki-272 and vinorelbine |
WO2010017163A1 (en) | 2008-08-04 | 2010-02-11 | Wyeth | Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |
KR20140036332A (en) | 2009-04-06 | 2014-03-25 | 와이어쓰 엘엘씨 | Treatment regimen utilizing neratinib for breast cancer |
CA2780332C (en) | 2009-11-09 | 2018-01-30 | Wyeth Llc | Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
DK2498756T4 (en) | 2009-11-09 | 2023-03-20 | Wyeth Llc | TABLET FORMULATIONS OF NERATINIM MALEATE |
CN104447541A (en) * | 2013-09-16 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | Bosutinib compound |
CN105384686B (en) * | 2014-09-04 | 2019-07-26 | 连云港润众制药有限公司 | A kind of bosutinib method for crystallising |
JP2019513754A (en) * | 2016-04-08 | 2019-05-30 | 塩野義製薬株式会社 | Stabilized solid preparation |
JP7086938B2 (en) | 2017-03-31 | 2022-06-20 | 日精エー・エス・ビー機械株式会社 | Resin container |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6297258B1 (en) | 1998-09-29 | 2001-10-02 | American Cyanamid Company | Substituted 3-cyanoquinolines |
EP1480679B1 (en) * | 2002-02-26 | 2007-05-23 | Astrazeneca AB | Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative |
SG145744A1 (en) | 2003-08-19 | 2008-09-29 | Wyeth Corp | Process for the preparation of 4-amino-3- quinolinecarbonitriles |
ES2322175T3 (en) * | 2004-09-17 | 2009-06-17 | EISAI R&D MANAGEMENT CO., LTD. | MEDICINAL COMPOSITION WITH IMPROVED STABILITY AND REDUCED GELIFICATION. |
AU2006266045A1 (en) * | 2005-07-01 | 2007-01-11 | Wyeth | Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile and methods of preparing the same |
WO2008053295A2 (en) * | 2006-10-30 | 2008-05-08 | Wockhardt Research Centre | Pharmaceutical compositions of benzoquinolizine-2-carboxylic acid |
CN101224185A (en) * | 2007-12-11 | 2008-07-23 | 山东蓝金生物工程有限公司 | Bosutinib sustained release implant for treating solid tumors |
-
2010
- 2010-06-30 MX MX2012000048A patent/MX2012000048A/en not_active Application Discontinuation
- 2010-06-30 SG SG2011094950A patent/SG177309A1/en unknown
- 2010-06-30 WO PCT/US2010/040555 patent/WO2011002857A2/en active Application Filing
- 2010-06-30 BR BRPI1015941A patent/BRPI1015941A2/en not_active Application Discontinuation
- 2010-06-30 CN CN2010800294791A patent/CN102470109A/en active Pending
- 2010-06-30 AU AU2010266342A patent/AU2010266342A1/en not_active Abandoned
- 2010-06-30 EP EP10732568A patent/EP2448563A2/en not_active Withdrawn
- 2010-06-30 RU RU2011152105/15A patent/RU2011152105A/en unknown
- 2010-06-30 CA CA2766067A patent/CA2766067A1/en not_active Abandoned
- 2010-06-30 KR KR1020127002851A patent/KR20120046216A/en not_active Application Discontinuation
- 2010-07-01 JP JP2010151063A patent/JP2011012063A/en not_active Withdrawn
- 2010-07-01 TW TW099121740A patent/TW201113050A/en unknown
- 2010-07-02 AR ARP100102373A patent/AR077546A1/en not_active Application Discontinuation
-
2011
- 2011-12-29 IL IL217298A patent/IL217298A0/en unknown
-
2012
- 2012-01-17 ZA ZA2012/00366A patent/ZA201200366B/en unknown
Also Published As
Publication number | Publication date |
---|---|
SG177309A1 (en) | 2012-02-28 |
JP2011012063A (en) | 2011-01-20 |
BRPI1015941A2 (en) | 2016-04-19 |
MX2012000048A (en) | 2012-01-27 |
KR20120046216A (en) | 2012-05-09 |
EP2448563A2 (en) | 2012-05-09 |
AR077546A1 (en) | 2011-09-07 |
RU2011152105A (en) | 2013-08-10 |
WO2011002857A2 (en) | 2011-01-06 |
ZA201200366B (en) | 2012-10-31 |
TW201113050A (en) | 2011-04-16 |
WO2011002857A3 (en) | 2011-03-10 |
CN102470109A (en) | 2012-05-23 |
AU2010266342A1 (en) | 2012-01-19 |
CA2766067A1 (en) | 2011-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181755T1 (en) | Immediate release tablet formulations | |
IL253870B (en) | Certain amino-pyrimidines and pharmaceutical compositions comprising them | |
ZA201200366B (en) | 3-cyanoquinoline tablet formulations and uses thereof | |
EP2515946A4 (en) | Nanoconjugates and nanoconjugate formulations | |
IL214911A0 (en) | Solfonylated tetrahydroazolopyrazines and their use as medicinal products | |
ZA201108697B (en) | Quinoline derivatives-containing pharmaceutical composition | |
ZA201200722B (en) | Pharmaceutical composition and administrations thereof | |
HK1169960A1 (en) | Pharmaceutical formulation | |
PL2469142T3 (en) | Press fitting and its use | |
EP2474522A4 (en) | Agomelatine and pharmaceutical compositions thereof | |
PT2605757E (en) | Nalbuphine-based formulations and uses thereof | |
ZA201106702B (en) | Sceletium extract and uses thereof | |
GB0921001D0 (en) | Products and uses | |
ZA201200761B (en) | Tablet | |
ZA201200079B (en) | Pharmaceutical compositions and solid forms | |
AU330360S (en) | Tablet | |
SG10201401678TA (en) | Tablet and pestle therefor | |
GB0920041D0 (en) | Tablet | |
GB0902648D0 (en) | Pharmaceutical compounds and compositions | |
PL2491021T3 (en) | Novel acylpiperazinones and their use as pharmaceuticals | |
GB0908317D0 (en) | Pharmaceutical compounds and compositions | |
GB0906703D0 (en) | Excipients and their use | |
GB0903145D0 (en) | Medicaments uses and methods | |
AU331949S (en) | Tablet | |
AU330359S (en) | Tablet |